Hydroxy-Safflower Yellow A Alleviates Osteoporosis in Ovariectomized Rat Model by Inhibiting Carbonic Anhydrase 2 Activity

Background: To investigate the therapeutic effect of Hydroxy-safflower yellow A (HSYA) on rat’s osteoporosis and explore its potential mechanism of action. Methods: Bilateral ovariectomized female rats (OVX) were used to establish a postmenopausal rat model of osteoporosis. HSYA was given as an intervention, and estradiol was used as a positive control. The levels of serum alkaline phosphatase (ALP), calcium ion (Ca2+), and inorganic phosphorus (IP) were used to detect bone loss. Three months after modeling, the rats were sacrificed and the rat’s ovaries, kidneys, tibia, and femur were used to calculate the organ index. The bone marrow of the femur of the rats was stained with Giemsa staining. The femur strength of rats was measured by INSTRON. The degree of osteoporosis was detected by pathological staining after decalcification of bone tissue. Predicted the main targets of HSYA in combination with bioinformatics, and the proteins related to osteoclast differentiation were detected in combination with western blotting. The effect of HSYA on the differentiation of RAW264.7 cells into osteoclasts was observed. Results: The Giemsa staining and serum test results showed that the operation was successful and affected bone metabolism. In the bone strength test, HSYA significantly increased the maximum threshold of femoral load in rats. Pathological examination showed that tibial cartilage, trabecular bone, and cortex significantly increased after treatment with HYSA. The number of osteoblasts increased while the number of osteoclasts decreased—elevated levels of type I and III collagen. Autodock was used for molecular docking of potential targets of HSYA. qPCR and western blot were used to show that the expression levels of CA2 and osteoclast differentiation-related proteins were significantly decreased after HSYA treatment. Cell level results showed that HSYA could inhibit the activity of osteoclasts and the ability of RAW264.7 cells to differentiate into osteoclasts. Conclusion: HSYA can inhibit the differentiation and formation of osteoclasts by inhibiting the expression of CA2 and relieving osteoporosis symptoms in OVX rats.

[1]  J. Duarte,et al.  Association between Visceral and Bone Marrow Adipose Tissue and Bone Quality in Sedentary and Physically Active Ovariectomized Wistar Rats , 2021, Life.

[2]  Honglin Chen,et al.  Plastrum testudinis extract suppresses osteoclast differentiation via the NF-κB signaling pathway and ameliorates senile osteoporosis. , 2021, Journal of ethnopharmacology.

[3]  X. Tong,et al.  Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants , 2021, Frontiers in Pediatrics.

[4]  L. Ginaldi,et al.  Hyperhomocysteinemia is Associated with Inflammation, Bone Resorption, Vitamin B12 and Folate Deficiency and MTHFR C677T Polymorphism in Postmenopausal Women with Decreased Bone Mineral Density , 2020, International journal of environmental research and public health.

[5]  T. Paul,et al.  Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis , 2020, Archives of Osteoporosis.

[6]  Jingwen Yang,et al.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases , 2020, Science Translational Medicine.

[7]  Yitao Wang,et al.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine , 2019, Chinese Medicine.

[8]  W. Xue,et al.  Cav1.3 is upregulated in osteoporosis rat model and promotes osteoclast differentiation from preosteoclast cell line RAW264.7 , 2019, Journal of cellular physiology.

[9]  Li Yang,et al.  Microbial osteoporosis: The interplay between the gut microbiota and bones via host metabolism and immunity , 2019, MicrobiologyOpen.

[10]  Dawei Zhang,et al.  Hydroxysafflor Yellow A Promoted Bone Mineralization and Inhibited Bone Resorption Which Reversed Glucocorticoids-Induced Osteoporosis , 2018, BioMed research international.

[11]  I. Akkawi,et al.  Osteoporosis: Current Concepts , 2018, Joints.

[12]  Soo Young Lee,et al.  Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation , 2017, Molecules and cells.

[13]  Shanshan Qi.  Synergistic Effects of Genistein and Zinc on Bone Metabolism and the Femoral Metaphyseal Histomorphology in the Ovariectomized Rats , 2017, Biological Trace Element Research.

[14]  Miho Nakamura,et al.  Osteoclasts and Remodeling Based Bone Formation. , 2016, Current stem cell research & therapy.

[15]  X. Guo,et al.  Deterioration of trabecular plate-rod and cortical microarchitecture and reduced bone stiffness at distal radius and tibia in postmenopausal women with vertebral fractures. , 2016, Bone.

[16]  D. Black,et al.  Clinical Practice. Postmenopausal Osteoporosis. , 2005, The New England journal of medicine.

[17]  H. Kato,et al.  Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover , 2015, Aging Clinical and Experimental Research.

[18]  A. A. Seif.  Nigella Sativa reverses osteoporosis in ovariectomized rats , 2014, BMC Complementary and Alternative Medicine.

[19]  Suiyi Tan,et al.  Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways , 2013, PloS one.

[20]  R. Baron,et al.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. , 2013, The Journal of clinical investigation.

[21]  Heather Ting Ma,et al.  Bone marrow fat content in the elderly: A reversal of sex difference seen in younger subjects , 2012, Journal of magnetic resonance imaging : JMRI.

[22]  J. Lee,et al.  Arctigenin suppresses receptor activator of nuclear factor κB ligand (RANKL)-mediated osteoclast differentiation in bone marrow-derived macrophages. , 2012, European journal of pharmacology.

[23]  P. Collin‐Osdoby,et al.  RANKL-mediated osteoclast formation from murine RAW 264.7 cells. , 2012, Methods in molecular biology.

[24]  S. Canpolat,et al.  Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats , 2010, Journal of Physiology and Biochemistry.

[25]  P. Bodine,et al.  Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. , 2008, Methods in molecular biology.

[26]  C. Supuran,et al.  Membrane-bound carbonic anhydrases in osteoclasts. , 2007, Bone.

[27]  S. Wysocki,et al.  17β-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats , 1995, Calcified Tissue International.

[28]  T. Matsumiya,et al.  Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. , 2002, Biological & pharmaceutical bulletin.

[29]  Väänänen Hk,et al.  Carbonic anhydrase II and H+ -ATPase in osteoclasts of four osteopetrotic mutations in the rat. , 1999 .

[30]  H. Väänänen,et al.  Carbonic anhydrase II and H+-ATPase in osteoclasts of four osteopetrotic mutations in the rat , 1999, Histochemistry and Cell Biology.

[31]  S. Coburn,et al.  Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. , 1998, The Journal of clinical endocrinology and metabolism.

[32]  P. Lehenkari,et al.  Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. , 1998, Experimental cell research.

[33]  S. Lindskog.  Structure and mechanism of carbonic anhydrase. , 1997, Pharmacology & therapeutics.

[34]  K. Väänänen,et al.  Proton channel part of vacuolar H+‐ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  A. Bailey,et al.  Biochemical changes in the collagen of human osteoporotic bone matrix. , 1993, Connective tissue research.